Sle (original) (raw)
Latest News for: sle
Man, 61, arrested after jumping out of ambulance on SLE
Straits Times 16 Jun 2026
The man was hit by a bus after jumping out of the emergency vehicle ....
Phase IIb Study Results of InnoCare’s Orelabrutinib in Patients with SLE Presented at 2026 EULAR
Nasdaq Globe Newswire 05 Jun 2026
The study showed that orelabrutinib was safe and well tolerated in participants with SLE ... .
2 taken to hospital following multi-vehicle collision on SLE
Straits Times 05 Jun 2026
One of the car drivers, a 40-year-old man, is assisting with investigations ....
Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity ...
Hartford City News Times 04 Jun 2026
Nipocalimab – the first and only neonatal Fc receptor ...
Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study
PR Newswire 03 Jun 2026
ABOUT SYSTEMIC LUPUS ERYTHEMATOSUSSystemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that occurs when the body's immune system mistakenly attacks its own healthy tissues.7,8 This ...
Man taken to hospital after car catches fire on SLE
Straits Times 01 Jun 2026
The car driver, a 26-year-old woman, is assisting with ongoing investigations, police said ....
SLE Technologies Expands Collision Platform Through Accudraft Partnership
Cadillac News 19 May 2026
MAXWELL, Ind.--(BUSINESS WIRE)--May 19, 2026-- ... .
B3 OFFICIAL LETTER 122/2026-SLE DATED MAY 15, 2026 – BRASKEM – REQUEST FOR CLARIFICATION REGARDING NEWS PUBLISHED IN THE MEDIA (Form 6-K) (Braskem SA)
Public Technologies 19 May 2026
) ... To ... CC ... B3 OFFICIAL LETTER 122/2026-SLE DATED MAY 15, 2026 - BRASKEM - REQUEST FOR CLARIFICATION REGARDING NEWS PUBLISHED IN THE MEDIA ... 122/2026-SLE ("Letter"), dated May 15, 2026, through which you requested clarifications from Braskem S.A.
Fate Therapeutics Showcases FT819 Clinical Activity in SLE without the use of Conditioning Chemotherapy at ...
Nasdaq Globe Newswire 11 May 2026
Single dose treatment of FT819 without conditioning ...
Police looking for lorry driver after hit-and-run accident on SLE
Straits Times 02 May 2026
Police said the lorry driver left the scene before they arrived ....
Answer to B3 Official Letter No. 56-2026-SLE (Banco do Brasil SA)
Public Technologies 01 May 2026
). Banco do Brasil S.A. Public-held Company. Corporate Taxpayer's Registry No. 00.000.000/0001-91. Company Registry 5330000063-8 INFORMATION TO THE MARKET. Banco do Brasil S.A ... B3 56/2026-SLE (the "Official Letter"), with the following statement..
Fate Therapeutics Announces Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Lupus Erythematosus (SLE) at the CCR – East 2026 Meeting (Fate Therapeutics Inc)
Public Technologies 30 Apr 2026
The Company is participating in a Poster Rounding Session and will present an encore of its clinical data from the systemic lupus erythematosus (SLE) study arm of its ongoing Phase 1 trial evaluating FT819 in various autoimmune diseases.
InnoCare Announces First Patient Dosed in Phase III Trial of Orelabrutinib for SLE
Nasdaq Globe Newswire 29 Apr 2026
Orelabrutinib is the first BTKi to demonstrate significant efficacy in a Phase II clinical trial for SLE, which affects around 8 million people worldwide ... .
SLE Market Evolution Accelerates as AstraZeneca’s Saphnelo SC Emerges as a Likely Key
Hastings Tribune 13 Apr 2026
Exton, PA, April 13, 2026 (GLOBE NEWSWIRE) -- The systemic ...
SLE Market Evolution Accelerates as AstraZeneca’s Saphnelo SC Emerges as a Likely Key Challenger to ...
Nasdaq Globe Newswire 13 Apr 2026
.